Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss.
DDR2 门控突变和 NF1 缺失导致肺癌细胞系对达沙替尼产生耐药性
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-13-0817
Beauchamp Ellen M, Woods Brittany A, Dulak Austin M, Tan Li, Xu Chunxiao, Gray Nathanael S, Bass Adam J, Wong Kwok-kin, Meyerson Matthew, Hammerman Peter S
